Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The main purpose of present study was to develop novel chitosan-modified polylactic-co-glycolicacid nanoparticles (CS@PLGA NPs) for improving the bio-availability of tolbutamide (TOL). The TOL-loaded CS@PLGA NPs (TOL-CS@PLGA NPs) were fabricated with the solvent evaporation method. The cargo-free CS@PLGA NPs showed a diameter of 228.3±2.5nm monitored with a laser light particlesizer, and the transmission electron microscope (TEM) photographs revealed their "core-shell" structures. The Zeta potential of the original PLGA NPs and the cargo-free CS@PLGA NPs was measured to be -20.2±3.21mV and 24.2±1.1mV, respectively. The changes in Zeta potential indicated the CS chains were coated on the surfaces of the original PLGA NPs. The thermal gravity analysis (TGA) curves suggested that the CS chains improved the thermostability of the original PLGA NPs. The results of cells viability indicated the cargo-free CS@PLGA NPs were nontoxicity. The in vitro release profiles suggested that TOL-CS@PLGA NPs could release TOL in pH 7.4 phosphate buffer solution (PBS) at a sustained manner. Streptozotocin (STZ) was employed to build the diabetic rat models. The physiological changes in the islet β cells confirmed the obtaining of diabetic rats. After treatment by gavage, the TOL-CS@PLGA NPs showed an excellent hypoglycemic effect. Therefore, the TOL-CS@PLGA NPs had a potential application in oral delivery of TOL.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.colsurfb.2017.10.037 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Inhibiting HO-Induced Aggregation of Human γD-Crystallin with Nanoformulations of Polyphenols.
Langmuir
July 2025
Department of Chemistry, Indian Institute of Technology Delhi, Hauz Khas, New Delhi 110016, India.
Cataract, one of the leading causes of vision loss, is primarily caused by the aggregation of crystallin proteins in the eye lens. This research work examines how oxidative stress, triggered by HO, influences the aggregation of human γD-crystallin. Techniques such as turbidity assay, thioflavin T (ThT) assay, circular dichroism (CD) spectroscopy, 1-anilinonapthalene-8-sulfonate (ANS) binding assay, Fourier transform infrared (FTIR) study, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis, and transmission electron microscopy (TEM) confirm the aggregation of protein in the presence of HO-forming fibrils.
View Article and Find Full Text PDFTargeted Nasal Route Delivery of Cationic Anti-TB Drug-Loaded Nano-embedded Microparticles for Mycobacterial Elimination in the CNS.
Mol Pharm
June 2025
Institute of Nano Science and Technology (INST), Knowledge City, Sector-81, SAS Nagar, Mohali 140306, Punjab, India.
Central nervous system tuberculosis (CNS-TB) is a severe and insidious form of extrapulmonary tuberculosis (TB) associated with a high mortality rate, often leading to fatal outcomes or debilitating neurological impairments. The therapeutic regimen for CNS-TB follows an approach similar to that of pulmonary TB but faces significant challenges in effectively reaching the cerebrospinal fluid and achieving therapeutic drug levels in the brain and surrounding fluids. A major obstacle in CNS-TB treatment is the difficulty in permeating the blood-brain barrier (BBB).
View Article and Find Full Text PDFRe-purposing of linagliptin for enhanced wound healing and skin rejuvenation via chitosan- modified PLGA nanoplatforms.
Int J Pharm
May 2025
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France. Electronic address:
Dipeptidyl peptidase IV (DPP IV) is a multifunctional glycoprotein implicated in the exacerbation of various inflammatory skin conditions, including wounds. Therefore, topical delivery of Linagliptin (LNG)-a DPP IV inhibitor- augmented with Lavender Oil (LO) could offer an excellent repurposed tool for the treatment of inflammatory skin diseases. LNG/ LO loaded chitosan (Cs) -modified Poly (Lactide co-Glycolic Acid) (PLGA) nanoparticles (LNG/LO-Cs/PLGA NPs) were prepared by solvent emulsification-evaporation technique.
View Article and Find Full Text PDFDisulfiram-Loaded PLGA nanoparticles modified with a Phenyl borate chitosan Conjugate enhance hepatic carcinoma treatment.
Int J Pharm
February 2025
Center for New Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou 510006 China; Guangdong Provincial Key Laboratory for Research and Evaluation of Pharmaceutical Preparations, Guangdong Pharmaceutical University, Guangzhou 510006 China; Guangdong Provincial Engineering Cen
Disulfiram (DSF), which has been traditionally used to treat alcoholism, has been shown to inhibit tumor growth, indicating its potential as an anticancer agent. However, its development and application are hindered by its poor water solubility, instability in physiological environments, and low bioavailability. In this study, phenylboronic acid-chitosan (PBA-CS) grafts were synthesized using the carbodiimide method.
View Article and Find Full Text PDFNanoencapsulation of vitamin B using chitosan-modified poly(lactic-co-glycolic acid) nanoparticles: Synthesis, characterization, and in vitro studies on simulated gastrointestinal stability and delivery.
J Food Sci
January 2025
Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok, Thailand.
Vitamin B, or riboflavin, is essential for maintaining healthy cellular metabolism and function. However, its light sensitivity, poor water solubility, and gastrointestinal barriers limit its storage, delivery, and absorption. Selecting suitable nanomaterials for encapsulating vitamin B is crucial to overcoming these challenges.
View Article and Find Full Text PDF